SCHEMBL16738024

SCHEMBL16738024

CN(C)C=Cc1cc([N+](=O)[O-])ccc1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
CYP3A4 P08684 1/20 0.51
ALOX15 P16050 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
HTT P42858 3/20 0.51
TP53 P04637 1/20 0.51
MAPT P10636 3/20 0.48
RAB9A P51151 1/20 0.47
POLB P06746 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
HCRTR1 O43613 1/20 0.42
LMNA P02545 1/20 0.42
ERN1 O75460 1/20 0.42
CTSV O60911 1/20 0.42
CTSL P07711 1/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
PTGES O14684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16738022 1.00 ALDH1A1 (0.55) ALDH1A1CYP3A4ALOX15TDP1HTT
SCHEMBL16738021 1.00 ALDH1A1 (0.55) ALDH1A1CYP3A4ALOX15TDP1HTT
SCHEMBL28899211 0.89 ALDH1A1 (0.58) ALDH1A1CYP3A4ALOX15TDP1HTT
SCHEMBL28899214 0.89 ALDH1A1 (0.58) ALDH1A1CYP3A4ALOX15TDP1HTT
SCHEMBL31351763 0.85 ALDH1A1 (0.44) ALDH1A1TDP1HTTTP53MAPT
SCHEMBL16294347 0.85 ALDH1A1 (0.44) ALDH1A1TDP1HTTTP53MAPT
SCHEMBL4406348 0.85 ALDH1A1 (0.44) ALDH1A1TDP1HTTTP53MAPT
SCHEMBL16744588 0.79 ALDH1A1 (0.53) ALDH1A1CYP3A4ALOX15TDP1HTT
SCHEMBL25338029 0.79 ALDH1A1 (0.59) ALDH1A1CYP3A4ALOX15TDP1HTT
SCHEMBL25338025 0.79 ALDH1A1 (0.59) ALDH1A1CYP3A4ALOX15TDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9174974-B2 Macrocyclic factor VIIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2015-11-03 US disclosed
US-20150148313-A1 MACROCYCLIC FACTOR VIIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2015-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150148313-A1 MACROCYCLIC FACTOR VIIA INHIBITORS F7, F12, F5 ALDH1A1 2542/4885CYP3A4 538/4885ALOX15 1853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.